Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 120202-66-6 | Product Number: C2556
(S)-(+)-Clopidogrel Sulfate
Purity: >98.0%(HPLC)(N)
- Methyl (S)-(+)-2-(2-Chlorophenyl)-2-[6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl]acetate Sulfate
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
1G |
$119.00
|
Contact Us | 1 | ≥40 |
|
5G |
$412.00
|
1 | 1 | ≥100 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | C2556 |
Purity / Analysis Method | >98.0%(HPLC)(N) |
Molecular Formula / Molecular Weight | C__1__6H__1__6ClNO__2S·H__2SO__4 = 419.89 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 120202-66-6 |
Related CAS RN | 113665-84-2 |
Reaxys Registry Number | 9967887 |
PubChem Substance ID | 125308051 |
MDL Number | MFCD00876395 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Optical Isomer | max. 0.5 % |
Purity(with Total Nitrogen) | min. 98.0 % |
Specific rotation [a]20/D | +54.0 to +58.0 deg(C=1, MeOH) |
NMR | confirm to structure |
Specific Rotation | 56° (C=1,MeOH) |
Solubility (soluble in) | Methanol |
HS Number | 2930.90.2900 |
References
- 1) P2Y12, a New Platelet ADP Receptor, Target of Clopidogrel
- 2) Identification of the platelet ADP receptor targeted by antithrombotic drugs
- 3) Clopidogrel: a review of its use in the prevention of thrombosis
- 4) Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
- 5) Developments in the synthesis of the antiplatelet and antithrombotic drug (S)-clopidogrel (a review)
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.